ClinicalTrials.gov record
Completed Phase 2 Interventional

Umbilical Cord Blood Transplantation in Treating Patients With High-Risk Hematologic Cancer

ClinicalTrials.gov ID: NCT00003335

Public ClinicalTrials.gov record NCT00003335. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 13, 2026, 11:55 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Pilot Study of Unrelated Umbilical Cord Blood Transplantation in Patients With High Risk Hematologic Malignancies

Study identification

NCT ID
NCT00003335
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Case Comprehensive Cancer Center
Other
Enrollment
44 participants

Conditions and interventions

Interventions

  • anti-thymocyte globulin Biological
  • busulfan Drug
  • cyclosporine Drug
  • melphalan Drug
  • methylprednisolone Drug
  • radiation therapy Radiation
  • umbilical cord blood transplantation Procedure

Biological · Drug · Radiation + 1 more

Eligibility (public fields only)

Age range
Up to 54 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 31, 1997
Primary completion
Oct 31, 2007
Completion
Dec 31, 2011
Last update posted
Mar 14, 2012

1998 – 2012

United States locations

U.S. sites
1
U.S. states
1
U.S. cities
1
Facility City State ZIP Site status
Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center Cleveland Ohio 44106-5065

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00003335, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 14, 2012 · Synced May 13, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00003335 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →